Cite
HARVARD Citation
Liu, L. et al. (2022). Cell division control 42 elevates during infliximab therapy, and its increment relates to treatment response in ulcerative colitis patients. Journal of clinical laboratory analysis. 36 (6), p. n/a. [Online].